Sareum (SAR) & Hemogenyx (HEMO): 2 LSE pharma stocks to buy today

Pharma and biotech-focused companies have seen huge investments after the onset of the pandemic. The UK received record levels of investment into its...

GSK and Unilever’s offer:  What shareholders can gain?

Highlights The consumer health business of GSK received multiple takeover bids, including a £50 billion bid just before Christmas in 2021 by...

AstraZeneca working on a new vaccine for Omicron:3 stocks to eye on

Highlights  FTSE 100 listed global pharmaceutical company AstraZeneca Pls said that it is working on developing a new vaccine for the Omicron...

Top 5 healthcare stocks of 2021

Highlights  Healthcare sector has shown tremendous growth amid the Covid-19 pandemic. The healthcare sector includes a range of companies pro...

GSK’s covid drug gets MHRA nod; maybe 'effective' against Omincron

Highlights  The UK-based GlaxoSmithKline has received initial approval from the UK regulator for its sotrovimab, a monoclonal antibody, which...

Omicron scare: WHO issues warning, healthcare stocks to invest in

Highlights  Initially detected in South Africa, the new Covid variant Omricon has created panic worldwide due to higher risk of re-infections....

Omega Diagnostics (ODX) shares slump over 30%: Should you hold?

Highlights  Omega Diagnostics Group reported a statutory loss of £2.75 million for the H1 2021, as its contract with the UK Departm...

Nuformix (NFX) & MyHealthChecked (MHC): 2 pharma penny stocks to buy

Highlights Nuformix published positive pre-clinical data on its new inhaled treatment NXP002 for idiopathic pulmonary fibrosis. MyHealthChecked ha...

AstraZeneca (AZN) shares: A long term buy from pharma space

Highlights AstraZeneca opened new research and development called Discovery Centre (DISC) is worth about £1 billion, in Cambridge It is the...

2 pharma penny stocks returning 200% in a year: Buy call?

Pharmaceutical firms often serve as attractive investment options for investors. These stocks belong to healthcare firms focused on research and devel...

AstraZeneca (AZN) or Nuformix (NFX): Which pharma stock to buy?

The UK pharma and biotechnology sector has laid out certain recommendations to increase the attractiveness of the sector, according to a new report by...

Sunak increases healthcare spending by £44 bn: 2 stocks to buy

The UK’s chancellor of exchequer, Rishi Sunak, boosted the UK’s resource expenditure on the healthcare sector in the Autumn Budget announc...

5 stocks that may benefit from Sunak’s new £1.4-bn investment fund

Highlights The UK government is planning to launch a £1.4bn fund to attract more overseas investments. Over £800 million of the new i...

100-300% return in a year! Should you buy these 2 AIM stocks?

Highlights ValiRx inked a contract with a renowned London university to test new technology for the treatment of breast cancer. As per the terms of...

GSK & AZN: 2 dividend-paying pharma stocks for income investors

The UK pharmaceutical industry is a major global hub for the research, development and production of pharmaceuticals and also plays a crucial role in...

GlaxoSmithKline (GSK): Should you hold it after split of headquarter...

Highlights GlaxoSmithKline announced plans for setting up two headquarters today, wherein its consumer healthcare business would have a new headqua...

Are these 2 pharma stocks good buy for long term growth?

Investing in pharmaceutical stocks is a growing trend, especially in times of political or economic uncertainty. For instance, during the Covid-19 cri...

Pfizer, J&J, AstraZeneca: What's the latest on Covid vaccines

Highlights  The US Food and Drug Administration approved the administration of a booster dose of the Pfizer/BioNTech vaccine in adults aged 65...

Abingdon (ABDX) soars 39%. Is this covid-19 testing stock still a bu...

Highlights UK-based rapid test developer and maker Abingdon Health shares surged over 38 per cent on Monday, making it the highest riser on the LSE...

Oxford Nanopore (ONT): What to expect after stellar listing?

UK based DNA sequencing biotechnology firm Oxford Nanopore Technologies PLC’s (LON: ONT) shares surged on listing on the LSE on Thursday, making...